Petaluma, CA – According to filings with the U.S. Securities and Exchange Commission, Spectrum Antimicrobials is raising $28,750,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Hojabr Alimi played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Spectrum Antimicrobials

Our mission at Spectrum Antimicrobials is to improve patient lives with innovative anti-infective solutions. Our team utilizes their scientific expertise and talent to passionately develop first-in-class products. Our R&D team has broken barriers of science in creating multiple platforms to eradicate antibiotic and multi-drug resistant pathogens. We have the opportunity to change the global standard of care for reducing the risk of infections. .

To learn more about Spectrum Antimicrobials, visit http://spectrumantimicrobials.com/

Contact:
Hojabr Alimi, Chief Executive Officer
707-668-7600

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved